PVI
SRPT icon

Pura Vida Investments’s Sarepta Therapeutics SRPT Stock Holding History

Pura Vida Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,850
Closed -$1.9M – 268
2022
Q1 		$2.02M Buy
+25,850
New +$1.98M 0.07% 159
2018
Q3 		– Sell
-16,000
Closed -$2.12M – 125
2018
Q2 		$2.12M Buy
+16,000
New +$1.51M 0.85% 42
2017
Q4 		– Sell
-50,000
Closed -$2.27M – 97
2017
Q3 		$2.27M Buy
50,000
+20,000
+67% +$799K 0.66% 53
2017
Q2 		$1.01M Buy
+30,000
New +$977K 0.4% 52
2016
Q4 		– Sell
-40,000
Closed -$2.46M – 89
2016
Q3 		$2.46M Buy
+40,000
New +$1.21M 0.75% 55

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pura Vida Investments's SRPT Position: Q2 2022 in Review

Pura Vida Investments sold out of Sarepta Therapeutics (SRPT) in Q2 2022, closing a stake of 25,850 shares — an estimated $1.9M sold.

Pura Vida Investments first reported a position in SRPT in Q3 2016 and held it in 5 quarters. The position peaked at $2.46M in Q3 2016. 332 funds tracked by Wall St. Rank hold SRPT as of Q2 2022.

  • Pura Vida Investments reported no remaining Sarepta Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 25,850 Sarepta Therapeutics shares in Q2 2022, an estimated $1.9M.
  • Pura Vida Investments first reported a position in Sarepta Therapeutics in Q3 2016 and held it in 5 quarters.
  • Pura Vida Investments's Sarepta Therapeutics position peaked at $2.46M in Q3 2016.
  • 332 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.